AN
Anwari Nuralli Gangrekar
About Anwari Nuralli Gangrekar
Data last updated:
Anwari Nuralli Gangrekar is a Director at Surgence Pharmatech Private Limited (since 2024). The company operates in Trading. Surgence Pharmatech Private Limited reported revenue of ₹2.42 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surgence Pharmatech Private Limited U51909MH2019PTC335180 | Director | 21 May 2024 | 2019 | ₹2.42 Cr (FY 2025) | Active |
Board colleagues of Anwari Nuralli Gangrekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nuralli Yunus Gangrekar | 08653075 | Surgence Pharmatech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anwari Nuralli Gangrekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anwari Nuralli Gangrekar
Anwari Nuralli Gangrekar currently holds 1 directorship: Surgence Pharmatech Private Limited (Director, since 21 May 2024, revenue ₹2.42 Cr (FY 2025)).
Anwari Nuralli Gangrekar was first appointed on 21 May 2024 as Director at Surgence Pharmatech Private Limited.
The current boards of Anwari Nuralli Gangrekar's companies include Nuralli Yunus Gangrekar (Surgence Pharmatech Private Limited).